Literature DB >> 24150509

i-STAT - Combining Chemistry and Haematology in PoCT.

Cameron L Martin1.   

Abstract

Point-of-care testing (PoCT) is traditionally considered a branch or offshoot of clinical chemistry. The appearance on the market of small, light, inexpensive, multi-purpose, point-of-care analysers, which combine a number of widely differing analytes, has to some degree upset this paradigm. Such analysers, however, are invaluable in some clinical settings. Specialties other than clinical chemistry may have differing views on traditional test management, particularly with regard to quality control (QC), quality assurance (QA), and training. These views must be considered when designing an overall PoCT management plan. Test management issues should be resolved by taking the view that it is a 'point-of-care' test, and by looking at the specific test technology and method involved, rather than by just assuming it is a 'haematology' or a 'chemistry' test. Clinical users of a combined PoCT system are principally interested in the generation of good quality results. To avoid confusion, any advice given to clinical staff regarding their analysers should be clear, concise, and above all else, consistent.

Year:  2010        PMID: 24150509      PMCID: PMC2924126     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  5 in total

1.  Point-of-care coagulation testing: stepping gently forward.

Authors:  M Laposata
Journal:  Clin Chem       Date:  2001-05       Impact factor: 8.327

2.  A risk management perspective on point-of-care testing.

Authors:  M M Cooney
Journal:  MLO Med Lab Obs       Date:  1991

Review 3.  Point-of-care-testing and Clinical Governance.

Authors:  Joan Pearson
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

4.  ICSH Guideline for worldwide point-of-care testing in haematology with special reference to the complete blood count.

Authors:  C Briggs; J Carter; S-H Lee; L Sandhaus; R Simon-Lopez; J-L Vives Corrons
Journal:  Int J Lab Hematol       Date:  2008-04       Impact factor: 2.877

5.  Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting.

Authors:  Gary W Moore; Alexis Henley; Shawn S Cotton; Sanjiv Tugnait; Savita Rangarajan
Journal:  Blood Coagul Fibrinolysis       Date:  2007-04       Impact factor: 1.276

  5 in total
  5 in total

1.  Real-time and Label-free Bio-sensing of Molecular Interactions by Surface Plasmon Resonance: A Laboratory Medicine Perspective.

Authors:  Erik Helmerhorst; David J Chandler; Matt Nussio; Cyril D Mamotte
Journal:  Clin Biochem Rev       Date:  2012-11

2.  Automated end-to-end blood testing at the point-of-care: Integration of robotic phlebotomy with downstream sample processing.

Authors:  M L Balter; J M Leipheimer; A I Chen; A Shrirao; T J Maguire; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2018-06

Review 3.  Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population.

Authors:  Anubhuti Saha; Ashutosh Bajpai; Vinay Krishna; Shantanu Bhattacharya
Journal:  Sensors (Basel)       Date:  2021-04-09       Impact factor: 3.576

4.  Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa.

Authors:  Naseem Cassim; Lindi M Coetzee; Abel L Makuraj; Wendy S Stevens; Deborah K Glencross
Journal:  Afr J Lab Med       Date:  2021-11-30

Review 5.  Point-of-Care Diagnostics in Low Resource Settings: Present Status and Future Role of Microfluidics.

Authors:  Shikha Sharma; Julia Zapatero-Rodríguez; Pedro Estrela; Richard O'Kennedy
Journal:  Biosensors (Basel)       Date:  2015-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.